Business / Finance

RSS

Amedica signs distribution agreement with K2M

Amedica Corporation, a biomaterial company, announced today that it has entered into a distribution agreement with K2M that will provide surgeons and hospitals in Europe with access to Amedica's Silicon Nitride interbody spinal fusion devices.

24 Oct 2013

ICON Q3 net revenues increase 19% to $339.8 million

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter ended September 30, 2013.

24 Oct 2013

MedRisk acquires Medical Diagnostic Associates Management

MedRisk, Inc., the nation's leading provider of physical medicine management to the workers' compensation industry, has acquired Medical Diagnostic Associates Management, Inc. based in Calabasas, Calif., and its access to a national diagnostic imaging network.

24 Oct 2013

McKesson agrees to acquire majority stake in Celesio

McKesson Corporation, a leading North American healthcare services and information technology company, and Celesio AG, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, announced today that McKesson has signed an agreement to acquire a majority stake in Celesio for €23 per share and to launch parallel voluntary public tender offers for the remaining publicly-traded shares and outstanding convertible bonds of Celesio.

24 Oct 2013

MEDICREA records over 60% of sales in third quarter 2013

The MEDICREA Group, which specializes in the development of innovative surgical technologies for the treatment of spinal pathologies, listed on Alternext by NYSE - Euronext Paris, announces its sales for the third quarter of 2013, ended September 30.

23 Oct 2013

Accelera Innovations, Lambert Private Equity sign Investment Agreement to support growth initiatives

Accelera Innovations, Inc. a Chicago-based healthcare software-as-a-service provider (the "Company") today announced it has entered into a Standby Equity Purchase Agreement ("Investment Agreement") with Lambert Private Equity, LLC, (the "Investor").

23 Oct 2013

Imugene Acquiring Biolife, As Lead Pipeline Candidate Nears Phase II

...

23 Oct 2013

Cleveland Biolabs Subsidiary Awarded $4.6M Russian Contract

...

23 Oct 2013

Startup Wins Five-Year Exclusive License To Decode Genetics Platform

...

23 Oct 2013

CoLucid signs distribution and supply agreement with ILDONG for Lasmiditan

CoLucid Pharmaceuticals, Inc., and ILDONG Pharmaceutical Co., Ltd., announced today that they have entered into a distribution and supply agreement for Lasmiditan in South Korea and Southeast Asia.

23 Oct 2013

Orygen To Manufacture Epirus' Remicade Biosimilar In Brazil

...

22 Oct 2013

Amgen Buys Roche Rights To Neutropenia Drugs

...

22 Oct 2013

Novozymes, Almac Ally To Offer Drug Targeting, Pharmacokinetics Service

...

22 Oct 2013

PDL Biopharma Acquires Diabetes Royalty, Milestone Rights For $240.5M

...

22 Oct 2013

diaDexus amends agreement with Comerica Bank to expand existing loan facility

diaDexus, Inc., a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it has amended its agreement with Comerica Bank to expand its existing loan facility from $5 million to $10 million.

22 Oct 2013

IDEXX Laboratories' revenues increase 7.2% to $338.3 million in Q3 2013

IDEXX Laboratories, Inc., today reported that revenues for the third quarter of 2013 increased 7.2% to $338.3 million, from $315.5 million for the third quarter of 2012.

22 Oct 2013

Nu Skin Enterprises Q3 revenue increases 76% to $927.6 million

Nu Skin Enterprises, Inc. today announced record third-quarter results with revenue of $927.6 million, a 76 percent increase over the prior-year period. Revenue was negatively impacted 3 percent by foreign currency fluctuations. Earnings per share for the quarter were $1.80, a 107 percent year-over-year improvement.

22 Oct 2013

InnoCore, Allergan expand collaboration to develop ophthalmology medicines

InnoCore Pharmaceuticals today announced that it has signed an exclusive License and Collaboration Agreement with Allergan, Inc., a multi-specialty health care company headquartered in Irvine, California.

22 Oct 2013

Univar signs agreement with Swati Spentose to become exclusive distributor of Lidocaine products

Univar Inc., a leading global chemical distributor, announced today that it has entered into an agreement with Swati Spentose Pvt. Ltd. to become its exclusive distributor of Lidocaine products, including Lidocaine Base and Lidocaine HCl in the United States.

22 Oct 2013